Antibody-enhanced pneumococcal adherence requires IgA1 protease.
about
Secretory IgA: Designed for Anti-Microbial DefenseThe role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfacesThe genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in childrenThe three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in miceSalivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.Molecular basis of host specificity in human pathogenic bacteriaSubdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant ProteinDevelopment of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteinsRapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suisA peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceIdentification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.Evolution of Streptococcus pneumoniae and its close commensal relatives.Pathogen-specific antibodies: codependent no longerPotential role for mucosally active vaccines against pneumococcal pneumoniaInhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulenceIdentification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease.Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma.Pneumococcal IgA1 protease subverts specific protection by human IgA1Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniaeInterleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation.Pneumococcal vaccine development.Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage.Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.Comparative Genomic Analysis of Meningitis- and Bacteremia-Causing Pneumococci Identifies a Common Core Genome.Understanding pneumococcal serotype 1 biology through population genomic analysis.Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysisIdentification of an atypical zinc metalloproteinase, ZmpC, from an epidemic conjunctivitis-causing strain of Streptococcus pneumoniae.Secretory immunity with special reference to the oral cavity.Do salivary antibodies reliably reflect both mucosal and systemic immunity?The pneumococcus: epidemiology, microbiology, and pathogenesisGenes and molecules of lactobacilli supporting probiotic action.Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses.Virulence factors in pneumococcal respiratory pathogenesis.Anatomical site-specific contributions of pneumococcal virulence determinants.Capsular Polysaccharide Expression in Commensal Streptococcus Species: Genetic and Antigenic Similarities to Streptococcus pneumoniae.Internalization and trafficking of nontypeable Haemophilus influenzae in human respiratory epithelial cells and roles of IgA1 proteases for optimal invasion and persistence.
P2860
Q21131208-CE7E09C7-DC31-4B11-A73B-7531843319EDQ21131627-D8B25C7C-7645-4030-941E-EFF8F344D896Q22066391-C79A127F-709D-4CBB-91CD-D182B965ACC1Q24684017-D2944463-C240-4D3C-BB50-627FAC3A2002Q24807198-EA74449E-1F5D-474D-8910-79342DA49303Q24812739-192171D5-C15F-426D-877B-84BBE1F16460Q26864388-1F9BB35D-2A99-4FB9-8B5A-327F81034874Q27304777-2C519B3C-6159-4DEB-AC64-2F3305FBDFD3Q28386732-72FF892F-98CD-45B2-A05C-15D0DFEE8D72Q28475752-FB2D3777-83EB-4034-A90F-B99A72CD97DDQ31137207-CC2F4253-F720-4111-80B3-B9B834A2DEFDQ33311002-CE31E40B-730D-42E9-A11C-E3D5A8CB3CE3Q33351980-7BC060C9-193F-49E8-A773-8ACE7F35D198Q33755471-D268A395-79F0-4A86-84FD-00B38CCC18C6Q33792681-7E7A60A8-1C59-44A9-8493-EB549DC0D37BQ33897480-EB0917AA-C06D-41B2-9526-8C2E9D371E40Q33900781-FB3F0F63-79F1-44EF-B039-AB792D5EA3EBQ34975633-E25C5923-8CC4-42F5-9AA2-1099F9389A6EQ35153766-49A95075-C46B-4217-925D-184EB112DEB8Q35684502-EDAFE5EB-2259-43D1-B530-0DBDDB76A65EQ35689073-14BBD6A0-95DE-485A-B537-1781CEC2FA97Q35783761-DFFB5004-3418-4ED6-AF62-59816AC56824Q35805458-43BA807C-953D-48DF-BC56-9D98CAB15A31Q35842291-FEB18B23-B65D-4FD3-8497-8FD98377A741Q35918513-0C8EDF9E-E9DA-41D9-BC91-F6241F0FC908Q35946160-BF4D5DE1-35CB-432F-8A75-7772AACB18F3Q36017775-C7C73284-D621-4662-96A5-9FE2C188D69BQ36053530-2B325B07-DAB0-496B-A438-712491ECAEADQ36184872-CAB7D288-1D00-4877-986A-20AA0C671FEFQ36594616-AE64A098-F56C-4A4E-9348-B56C0ABCFBB3Q36625755-80A626E5-EEA3-43F1-A51F-02C4A30A0027Q36678122-9DB8555A-341A-4725-B2A4-33AEBB5B94B7Q36792251-67F27040-1A3E-404D-8DE1-AC040D190974Q36938477-F9AB996B-68F4-45D7-BB37-124C194B4EA4Q36995291-463D9B47-D164-4C7D-BAB7-68F0A42EA6E9Q37032665-78AF3FA9-D773-4144-9F2F-7039097531C3Q37119044-DB73222E-879B-40E2-9A38-C56156108155Q37252799-77E2DB32-78B0-49A3-8C5F-987EA6D3018EQ37417367-B839E790-52E8-448F-9030-D3AD44681387Q37548212-3435157C-CB01-45A4-866D-84BE5939C33A
P2860
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@ast
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@en
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@nl
type
label
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@ast
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@en
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@nl
prefLabel
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@ast
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@en
Antibody-enhanced pneumococcal adherence requires IgA1 protease.
@nl
P2093
P2860
P356
P1476
Antibody-enhanced pneumococcal adherence requires IgA1 protease
@en
P2093
Claudine Fasching
Deborah Bae
Edward N Janoff
Ronald W Scamurra
P2860
P304
P356
10.1073/PNAS.0637469100
P407
P577
2003-03-17T00:00:00Z